11:42 AM EST - Oncolytics Biotech Inc : Hosted a key opinion leader (KOL) webinar featuring leading physicians in the fields of oncology and immunotherapy discussing pelareorep's robust clinical data and how it fits in the evolving treatment landscape for pancreatic and gastrointestinal cancers. The KOLs provided individual presentations and then participated in a roundtable Q&A discussion. Oncolytics Biotech Inc
shares T.ONC are trading off $0.02 at $1.59.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONC%3ACC&qmodStoryID=4643184604096128
